North American Prodromal Synucleinopathy Consortium

Trial ID or NCT#

NCT03623672

Status

recruiting iconRECRUITING

Purpose

This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.

Official Title

North American Prodromal Synucleinopathy Consortium

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Idiopathic REM sleep behavior disorder
Exclusion Criteria:
  1. - REM sleep behavior disorder secondary to another cause (ex: narcolepsy, dementia, Parkinson's Disease, etc) - Other neurological disorder
View All Criteria
Show Less

Investigator(s)

Emmanuel During, MD

View on ClinicalTrials.gov